Mochtar, C A <br/><br/>
Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.  [electronic resource] 

 -  Urology  Feb 2005 
 - 300-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/j.urology.2004.09.030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-Antagonists--therapeutic use<br/>Aged<br/>Biomarkers--blood<br/>Case Management<br/>Follow-Up Studies<br/>Humans<br/>Life Tables<br/>Male<br/>Middle Aged<br/>Organ Size<br/>Prognosis<br/>Proportional Hazards Models<br/>Prostate--pathology<br/>Prostate-Specific Antigen--blood<br/>Prostatectomy--statistics & numerical data<br/>Prostatic Hyperplasia--blood<br/>Risk<br/>Urinary Bladder Neck Obstruction--etiology<br/>Urinary Retention--etiology